XNAS: EDIT
Editas Medicine Inc Live Stock Price Today, Share Analysis and Chart
about
Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary gene editing platform base...
Read More
2.92
0.04
(1.39%)
408.9K
XNAS Volume
XNAS 17 Jul, 2026 10:18 AM (EDT)
Low Financial Strength
Expensive Valuation
Technically Neutral
Momentum Trap
These stocks have weak financials and expensive valuation. Medium technical scores may weaken. Investors should exercise caution
View Similar
Embed DVM
Editas Medicine Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..